CDC

Oral Surgeon Renews Suit Against Rhode Island Covid-19 Vaccine Mandate, as CDC Eases Guidelines

Retrieved on: 
Friday, August 19, 2022 - 4:22pm
Rhode Island Department of Health, Medicaid, Safety, Vaccination, Work, District court, Immunity, Government, The Administrative State, COVID-19, Recurrence, Â, Infection, Centers for Disease Control and Prevention, Science, Palsy, N95, NCLA, Severe acute respiratory syndrome coronavirus 2, Center, State, District, GLOBE, Medicare, Movement, History, Douglas v. U.S. District Court ex rel Talk America, Screaming, Risk, CDC, Employment, Patient, Vaccine, Pharmaceutical industry, Public relations

Even so, the State of Rhode Island has put in place an irrational Covid-19 vaccine mandate on medical professionals, including those who have natural immunity to the virus.

Key Points: 
  • Even so, the State of Rhode Island has put in place an irrational Covid-19 vaccine mandate on medical professionals, including those who have natural immunity to the virus.
  • Rhode Islands order , updated in June, adds a new, not-publicly-discussed section to an existing temporary emergency regulation issued by the Rhode Island Department of Health (RIDOH) in 2021.
  • The new rule requires all Medicare and Medicaid certified providers, suppliers, and healthcare workers to get the Covid-19 vaccine.
  • With this lawsuit, it is hoped that Rhode Island can be pushed, kicking and screaming if necessary, to accept the science of naturally acquired immunity to Covid.

Wolters Kluwer expert discusses CDC director’s new push for preprints

Retrieved on: 
Friday, August 19, 2022 - 1:30pm
Science, Public Policy, Government, Research, White House, Federal Government, General Health, Health, COVID-19, Other Health, Interview, Press, Risk, Faculty, Associated Press, Technology, Student, COVID, Center, Nature Research, Learning, Lawyer, Research, Compliance, Nursing, Patient, CDC, General manager, Pearson Education, DOI, Pandemic, MPH, Korea Disease Control and Prevention Agency, WKL, Harvard University, Solution, LinkedIn, Preprint, Medicine, Efficiency, Wolters Kluwer, Cryptocurrency, Pharmaceutical industry, Management, Physics, MD

Like published articles, preprints often get a digital object identifier (DOI) so they can be cited by other researchers in subsequent articles and reports.

Key Points: 
  • Like published articles, preprints often get a digital object identifier (DOI) so they can be cited by other researchers in subsequent articles and reports.
  • Researchers that opt for preprints circumvent a potentially protracted peer-review process which can take months to sometimes years.
  • Who: Vikram Savkar is the Senior Vice President and General Manager for the Medicine Segment of the Health Learning, Research & Practice business at Wolters Kluwer.
  • Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare.

CED Issues Statement on CDC Director's Call for Major Reforms of the Agency

Retrieved on: 
Thursday, August 18, 2022 - 9:34pm
Monkeypox, Public health, Committee for Economic Development, The Conference Board, Policy, Center, CED, Communication, CDC, Centers for Disease Control and Prevention, Economic development, Solution, Conference, Public policy, Committee, Pharmaceutical industry, Risk management, Management

We share Dr. Walensky's goal of "a new, public health, action-oriented culture at the CDC that emphasizes accountability, collaboration, communication and timeliness."

Key Points: 
  • We share Dr. Walensky's goal of "a new, public health, action-oriented culture at the CDC that emphasizes accountability, collaboration, communication and timeliness."
  • These and other reforms will help the agency respond much faster to public health emergencies, including the current monkeypox outbreak.
  • CEDTrustees are chief executive officers and key executives of leading US companies who bring their unique experience to address today's pressing policy issues.
  • Founded in 1916, we are a non-partisan, not-for-profit entity holding 501 (c) (3) tax-exempt status in the United States.

Favor Teams Up with imaware to Offer Discrete At-Home STI Tests to Women and People Who Menstruate

Retrieved on: 
Thursday, August 18, 2022 - 2:00pm
Woman, Reproductive health, MG, Biomarker, Chlamydia, CEO, GLOBE, Simplex, College, Syphilis, Technology, Telehealth, Prevalence, STI, Congenital syphilis, American Journal, Patient, CDC, COVID-19, Ureaplasma urealyticum, Gonorrhea, Preventive healthcare, Men's Health, Coronavirus, CAP, HIPAA, Mycoplasma genitalium, Clinical Laboratory Improvement Amendments, Trichomoniasis, American Journal of Preventive Medicine, Insurance, Digital, Solution, Degenerative disease, CLIA, Health, Birth control, Pharmaceutical industry

“Favor deeply understands women’s health and how unique each patient’s journey can be. STI testing is more than just a box and what’s inside; it’s critical to understand the worries and challenges that patients face when they go to get tested -- from cost of testing to sensitivities around discretion,” said Jani Tuomi, founder of imaware. “imaware was created to make scientifically validated tools for screening and monitoring health more accessible and convenient and we are extremely proud to be partnering with Favor, a company closely aligned with our own mission.”

Key Points: 
  • This custom, one-of-a-kind test kit goes beyond existing at-home STI tests on the market to provide women and people who menstruate with a more comprehensive and accurate picture of their reproductive health.
  • The STI test, and customer experience, leverages advanced capabilities of imaware, a leader in testing technology and digital health.
  • As an antidote to the screening gap, imaware has developed its first at-home STI test that is accessible, convenient and accurate.
  • Favor is the nations leading integrated digital healthcare platform on a mission to empower women and people who menstruate to lead their healthiest lives.

Father Invents Balance Treatment Device for Daughter; Makes History with FDA Clearance AND Breakthrough Device Designation

Retrieved on: 
Thursday, August 18, 2022 - 1:31pm
FDA, Interview, Nausea, Multimedia, Depression, Yang, Lists of diseases, Mackenzie, CEO, Medicare, Disease, Amnesia, Diagnosis, Dizziness, Standard of care, Technology, Brain, Wood, Falls, Injury, Post-concussion syndrome, Research, CO, Marketing, Patient, CDC, Fatigue, Statistics, SOC, Cerebral palsy, Headache, Anxiety, University, Insurance, Mayo Clinic, Dysautonomia, Pharmaceutical industry, Medical device, Medicaid

COLORADO SPRINGS, Colo., Aug. 18, 2022 /PRNewswire/ -- On April 27, 2022, GyroStim became the first FDA-cleared device for treating balance disorders to receive FDA designation as a Breakthrough Device. This new balance treatment technology has potential to prevent falls and save the healthcare industry billions of dollars each year.

Key Points: 
  • With FDA clearance and breakthrough designation, UltraThera Technologies is poised to disrupt the healthcare industry and cut healthcare costs by billions of dollars annually.
  • GyroStim is only the 46th medical device in FDA history to be both designated as a Breakthrough Device and cleared for marketing.
  • The FDA grants Breakthrough Device designation only to products the agency determines can "provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating human disease or conditions" (FDA.gov).
  • It provides therapeutic treatment for balance disorders resulting from injury, illness, and neurological or aging-related conditions.

InvestmentPitch Media Video Discusses LOVE Pharma’s Definitive Agreement to Acquire Doc Hygiene Pharmaceuticals Inc.

Retrieved on: 
Thursday, August 18, 2022 - 11:00am
FDA, DOC, Intellectual property, Risk, FSE, United Kingdom, CEO, GLOBE, Hygiene, Wellness, Canadian Securities Exchange, Vitamin E, Aloe vera, Health minister, Quality of life, CDC, Suggestion, Acquisition, Awareness, LOVE, B2B, Health, News, CSE, SKU, Generic drug, Online shopping

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

Key Points: 
  • A Media Snippet accompanying this announcement is available by clicking on the image or link below:
    For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company.
  • Designed and developed in the United States, DOC HYGIENE provides a mess-free, compact alternative to traditional, bulky, bottled hand sanitizer.
  • With premium, germ-killing capability, DOC HYGIENEs single-use hand sanitizing packets meet FDA standards and exceed the recommended CDC guidelines for healthy hygiene.
  • Love Pharma has paid a fee not exceeding $2,000 in cash to have its current news release produced in video format.

Preparing for Continuing Battle with COVID, MicroGEM Partners with Medline to Equip Healthcare Providers with World's First Saliva PCR Test for Point of Care

Retrieved on: 
Wednesday, August 17, 2022 - 7:10pm
FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Multimedia, Biomarker, Acceleration, Laboratory, Precision medicine, Federal Food, Drug, and Cosmetic Act, NIH, Omicron, United States Department of Health and Human Services, Disaster medicine, R, Diagnosis, EUA, BBC, COVID, Center, National Institute, Molecular biology, National, Saliva, Department, Government, Human services, Patient, CDC, COVID-19 contracts in the United Kingdom, COVID-19, Infection, Medical imaging, View, Partnership, RNA, Virus, Biological engineering, Korea Disease Control and Prevention Agency, National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering, Solution, Severe acute respiratory syndrome coronavirus 2, Live, PCR, Medicine, Food, Efficiency, COVID-19 testing, Pharmaceutical industry, Medical device, MEDLINE

CHARLOTTESVILLE, Va., Aug. 17, 2022 /PRNewswire/ -- MicroGEM, a U.S.-based molecular biology company, today announced that Medline, a manufacturer and distributor of medical supplies to healthcare providers across the continuum of care, is now offering the MicroGEM Sal6830 Point of Care PCR System and SARS-CoV-2 Saliva Test.

Key Points: 
  • "Our partnership with MicroGEM expands our product portfolio to offer a saliva-based test for the first time.
  • Medline is a healthcare company; a manufacturer, distributor, and solutions provider focused on improving the overall operating performance of healthcare.
  • Partnering with healthcare systems and facilities across the continuum of care, Medline provides the clinical and supply chain resources required for long-term financial viability in delivering high-quality care.
  • Headquartered in Northfield, Ill., Medline has 30,000+ employees worldwide and does business in more than 125 countries and territories.

Global Medical Gas Market Report to 2030 - Increasing Demand for Home Healthcare and Point of Care Diagnostics is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 17, 2022 - 4:11pm
Health, Medical Supplies, Medical Devices, Adoption, Medicine, DIY, Industry, Degenerative disease, Growth, Hospital, Prevalence, Patient, CDC, Health, Conditional sentence, Awareness, CAGR, WHO, Powerex, Disease management, Diabetes, USD, Nurse Next Door Home Healthcare Services, Medical device, Health insurance, Pharmaceutical industry

The global medical gas market size is anticipated to reach USD 25.6 billion by 2030.

Key Points: 
  • The global medical gas market size is anticipated to reach USD 25.6 billion by 2030.
  • The market is expected to expand at a CAGR of 8.1% from 2022 to 2030.
  • Furthermore, increased demand for advanced medical gas equipment such as vacuum systems and manifolds, are expected to drive market growth.
  • The growing awareness about chronic diseases, rising adoption of technologically advanced therapeutic and diagnostic products is projected to contribute to the regional market growth .

UMF Corporation Calls for Nominations for First Annual Education Hygiene Specialist Excellence Award

Retrieved on: 
Wednesday, August 17, 2022 - 3:19pm
Multimedia, Risk, Eating, UMF, American Journal of Infection Control, Crash, Research, EPA, Subclinical infection, American Journal, CDC, COVID-19, School, Education, Disinfectant, Infection, Safety, Color, University, List X site, LinkedIn, Student, Health, Medicine, Pharmaceutical industry

NORTHBROOK, Ill., Aug. 17, 2022 /PRNewswire/ -- UMF Corporation today opened nominations for its first annual Education Hygiene Specialist Excellence Award, which acknowledges the contributions of janitorial staff at K-12 schools, colleges and universities across the country. Modeled on UMF's Hygiene Specialist and Guest Room Attendant Excellence Awards for healthcare and hospitality, respectively, the Education Hygiene Specialist Excellence Award recognizes the crucial role school custodians play in providing a safe hygienic environment for students, teachers, and staff. Nominations are open through December 31, 2022.

Key Points: 
  • NORTHBROOK, Ill., Aug. 17, 2022 /PRNewswire/ -- UMF Corporation today opened nominations for its first annual Education Hygiene Specialist Excellence Award , which acknowledges the contributions of janitorial staff at K-12 schools, colleges and universities across the country.
  • Modeled on UMF's Hygiene Specialist and Guest Room Attendant Excellence Awards for healthcare and hospitality, respectively, the Education Hygiene Specialist Excellence Award recognizes the crucial role school custodians play in providing a safe hygienic environment for students, teachers, and staff.
  • "We are privileged to introduce the first annual Education Hygiene Specialist Excellence Award to acknowledge the custodial staff whose jobs are critical in mitigating the risk of infections among students, teachers, and staff.
  • The Education Hygiene Specialist Excellence Award is one way to do just that."

Telehealth Market Worth $539.73 Billion by 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Retrieved on: 
Wednesday, August 17, 2022 - 3:00pm
Cloud, Well, Movement, Cardiology, Dermatology, Telehealth, Intelligence, Peripheral, Technology, Growth, Telecommunication, Radiology, ICU, Confidentiality, Hospital, Prevalence, ECG, Government, Patient, CDC, Telepsychiatry, COVID-19, Cerner, Conditional sentence, Awareness, Cisco Systems, Geography, CAGR, Research, Lists of countries and territories, Privacy, Physician, Component, RMON, Impact, Efficiency, Adoption, Healthcare, Pharmaceutical industry, Medical imaging, Software, Psychiatry

Similarly, reluctance to migrate from traditional systems, chances ofmisdiagnosis, and technological barriers in developing countries may pose challenges to market players.

Key Points: 
  • Similarly, reluctance to migrate from traditional systems, chances ofmisdiagnosis, and technological barriers in developing countries may pose challenges to market players.
  • Based on application, the telehealth market is segmented into psychiatry, radiology, cardiology, primary care, dermatology, remote ICU, and other applications.
  • Quick Buy Telehealth Market Research Report: https://www.meticulousresearch.com/Checkout/33290201
    Based on end user, the healthcare providers segment is estimated to account for the largest share of the market in 2022.
  • The telehealth market has witnessed several new product launches, approvals, partnerships & agreements, and acquisitions in recent years.